Lymph Node Metastasis Density and Growth Pattern as Independent Prognostic Factors in Advanced Esophageal Squamous Cell Carcinoma
- 24 August 2007
- journal article
- Published by Wiley in World Journal of Surgery
- Vol. 31 (11) , 2184-2191
Abstract
Background: Esophageal cancer is one of the leading types of cancer, and it is a particularly deadly form of malignancy. TNM classification is the most common staging system, but it has been reported that prognosis is not reflected adequately by this classification. The purpose of this study was to clarify independent prognostic factors in esophageal squamous cell carcinoma (ESCC), a dominant type of esophageal cancer in Japan, to broaden the staging system to improve its predictive value. Thus staging could be expanded to make the prognosis a valuable clinical tool, and to improve knowledge of the biological traits of advanced ESCC.Methods: The present study included 121 patients with advanced ESCC (stage II to IVA) treated by esophagectomy between 1990 and 2003 at the Kitasato University Higashi Hospital.Results: Univariate prognostic analysis of the disease‐specific survival revealed that TNM stage (p < 0.0001), lymph node metastasis density over 10% (ND10; p < 0.0001), R‐category (p = 0.003), intramural metastasis within the esophagus (IM; p = 0.009), growth pattern (p = 0.01), and size of tumor (p = 0.02) were significantly associated with a poor outcome in advanced ESCC. Multivariate analysis confirmed that growth pattern (p = 0.02, HR = 3.1) and ND10 (p = 0.02, HR = 2.0) were finally remnant prognostic factors independent of TNM stage. Growth pattern was prominent in stage II, whereas ND10 was directly proportional to stage progression and characteristics to stage IV disease. Interestingly, ND20, the most malignant phenotype of ESCC, was the only prognostic determinant, even in stage IV disease.Conclusions: From the present study, we concluded that progression of lymph node density is characteristic of a life‐threatening phenotype of advanced ESCC, and it should be employed as a therapeutic target to improve patient survival. Growth pattern is an alternative target characteristic of less advanced ESCC. Both of these parameters may be applied as useful clinical tools in the management of patients with advanced esophageal cancer.Keywords
This publication has 37 references indexed in Scilit:
- Dysregulation of Claudin-7 Leads to Loss of E-Cadherin Expression and the Increased Invasion of Esophageal Squamous Cell Carcinoma CellsThe American Journal of Pathology, 2007
- Retinol decreases β‐catenin protein levels in retinoic acid‐resistant colon cancer cell linesMolecular Carcinogenesis, 2007
- Downstaging of T or N Predicts Long-Term Survival After Preoperative Chemotherapy and Radical Resection for Esophageal CarcinomaThe Annals of Thoracic Surgery, 2006
- The clinical impact of histopathologic response assessment by residual tumor cell quantification in esophageal squamous cell carcinomasCancer, 2006
- Management of locoregional stage esophageal cancer: a single center experienceDiseases of the Esophagus, 2006
- Plasma D-Dimer Levels Show Correlation with Number of Lymph Node Metastases in Patients with Esophageal CancerJournal of the American College of Surgeons, 2005
- COX-2, MMP-9, and Noguchi Classification Provide Additional Prognostic Information About Adenocarcinoma of the Lung: A Study of 117 Patients From BrazilAmerican Journal of Clinical Pathology, 2004
- Multivariate analysis of clinical, operative and pathologic features of esophageal cancer: who needs adjuvant therapy?Diseases of the Esophagus, 2002
- Oxaliplatin in Combination With Protracted-Infusion Fluorouracil and Radiation: Report of a Clinical Trial for Patients With Esophageal CancerJournal of Clinical Oncology, 2002
- Univariate and multivariate analyses of the prognostic significance of discontinuous intramural metastasis in patients with esophageal cancerJournal of Surgical Oncology, 1994